Rayner Newsroom

Dr Steve Arshinoff, Mr Sathish Srinivasan and Mr Manyank Nanavaty complete the panel of speakers for the Rayner-sponsored satellite symposium ‘Outcome Excellence in Cataract Surgery’ at the XXXIV ESCRS in Copenhagen, 10-14 September.

Introducing Ophteis^® FR Pro with sorbitol – for unparalleled Free Radical Scavenging (FRS)

On March 7th 2016, Rayner launches a new OVD – Ophteis^® FR Pro . Ophteis^® FR Pro with sorbitol is a revolution in OVDs, protecting the corneal endothelium from free radical energy caused by phaco emulsification.

The next step in the evolution of cataract surgery?

...

Professor Steve Arshinoff discusses the importance of viscoelastic in cataract surgery at Rayner's Ophteis Acquisition event at the 2015 ESCRS in Barcelona.

Also included in the video, Rayner CEO Tim Clover and Professor Steve Arshinoff welcome guests and briefly introduce Ophteis to the Rayner family before commencing the cutting of a celebratory cake.

Rayner will be hosting a very special ESCRS event to mark the recent acquisition of the Ophteis OVD portfolio.

Professor Steve Arshinoff and Rayner CEO Tim Clover will make a short speech before inviting guests to join the celebration with a glass of cava...

Rayner has acquired the ophthalmic cataract surgery business of Aptissen SA (Geneva, Switzerland).

The acquisition closes today, July 2, 2015.

Acquisition details

A group of Uganda’s poorest children have had the gift of sight restored and 4 Ugandan paediatric ophthalmologists have been educated on the modern methods of paediatric cataract surgery. These are the achievements of the latest teaching visit organised by the VISION 2020 LINKS programme, with the support of Rayner.

The company was honoured to be approached by surgeon, Mr Geoffrey Woodruff, FRCOphth, who requested a supply of Rayner’s premium quality monofocal IOLs (the Rayner C-flex) and some Rayvisc viscoelastic for his up-coming charity work in Uganda. The following is his report on his trip and its purpose.

Rayner IOL Ltd is proud to announce the addition of Rayflo 1.6% Sodium Hyaluronate solution to our product range. Rayflo combines maximum intraocular protection with the ease-of-use that modern ophthalmic surgeons expect.

Rayflo has superb qualities and advantages observable, for example, at each stage of the modern cataract procedure.